News and press | Viapath

Filter by:

9th August 2017

Viapath presentations at the Institute of Biomedical Science’s Congress

8th August 2017

Apprenticeships within pathology

Viapath has responded to the Government’s new Apprenticeship Levy scheme, by working with “3aaa Apprenticeships” to set up the VIAcademy.

8th August 2017

Faster approach to detecting common bacterial gastrointestinal pathogens by multiplex PCR in faecal samples

8th August 2017

Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma

8th August 2017

Major incident simulation & planning

Planning for major incidents from a pathology perspective.

David Wells

8th August 2017

Childhood cancer in Myanmar (Burma)

8th August 2017

The multi-disciplinary approach for the diagnosis of multiple myeloma

8th August 2017

In the spotlight: Viapath Customer Services

Viapath recently decided to expand its Customer Service department to develop the service offered.

Rupinder Gill

29th June 2017

Why urine steroid profiling is still the gold standard for identification of steroid-related disorders

How steroid metabolite analysis helped to diagnose a virilised (masculinised) female baby with 3BHSD deficiency.

Lea Ghataore

29th June 2017

How genetic and molecular innovation in pathology will improve NHS outcomes for patients

There is a revolution taking place in genetics No longer will genetic testing a confirmatory test but the starting point Personalised medicine will become the norm New technologies need to be rapidly introduced into pathology

Last updated: 17/06/2014

eMail alerts and news

Twitter LinkedIn RSS

Site details

Working with our NHS service partners to set the standard for the future of pathology

Viapath is a founding member of The Association of Independent Pathology Providers (AIPP), which is a trade association representing innovative research-based diagnostic testing companies. www.pathologyassociation.com

Copyright 2014 Viapath Group LLP. Viapath and the Viapath logo are registered trademarks of Viapath Group LLP.